Response to Orlandi.
Saved in:
| Title: | Response to Orlandi. |
|---|---|
| Authors: | Tarantino P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Breast Oncology Program, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Lee D; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, CT, United States., Soulos PR; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.; Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, CT, United States., Sammons S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Breast Oncology Program, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Lustberg M; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.; Yale Cancer Center, Smilow Cancer Hospital, New Haven, CT, United States. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2026 Jan 01; Vol. 118 (1), pp. 187-188. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
